Perception Capital Corp. II (PCCT) Shareholders Approve Spectaire Deal
by Marlena Haddad on 2023-10-13 at 5:37pm

Perception Capital Corp. II (NASDAQ:PCCT) announced that its shareholders approved its combination with equipment manufacturer Spectaire at a special meeting held earlier today.

At the meeting, holders of 1,534,487 Class A ordinary shares and 5,750,000 Class B ordinary shares were present, representing 92.26% of the issued and outstanding shares. The deal was overwhelmingly approved as holders of 7,013,879 shares voted in favor of the transaction and holders of just 210,608 shares voted against it.

While the SPAC has not yet revealed final redemption figures, it entered today’s shareholder vote revealing with a different 8-K this morning that 2,049,498 Class A Ordinary Shares had already redeemed, leaving it with approximately $22.3 million and just 31,417 shares. Perception II hit a high yesterday of $15.40, but closed today at $10.30, slightly below its estimated $10.72 pro rata cash in trust.

Earlier this week, Perception II secured a $3.5 million PIPE commitment from investor Dr. Jörg Mosolf. The initial purchase of 50,000 shares, at $10.00 per share, will happen concurrently with the closing of the deal for $500,000. Within two years after the closing, Dr. Mosolf will buy additional shares for $10.00 per share, totaling $3 million.

The SPAC also recently entered into a $650,000 agreement with Polar Multi-Strategy Master Fund to provide money for its expenses until the deal is finalized. In return, PCCT will give Polar 0.9 shares of common stock for every dollar provided.

Perception II inked the $203 million combination with Spectaire earlier this year in January and added a $25 million cash closing condition in March. Neither party has specified a timeline for finalizing the deal.

Watertown, Massachusetts-based Spectaire provides a precision micro mass spectrometer designed to help companies demonstrate carbon emission reductions.


Recent Posts
by Nicholas Alan Clayton on 2024-02-26 at 1:45pm

News and Rumors PR: Medtech firm Agiliti (NYSE:AGTI) has agreed to be acquired by an affiliate of private equity firm Thomas H. Lee Partners (THL) at $10 per share and an enterprise value of $2.5 billion. This represents a 43% premium over the company’s 90-day VWAP and returns it to 100% ownership by THL five...

by Nicholas Alan Clayton on 2024-02-26 at 7:42am

At the SPAC of Dawn The last week of February is to host a moderate amount of SPAC votes and also the potential for some market-moving data releases. Shareholders for five SPACs are to consider extensions this week and seven more SPACs have scheduled completion votes. But, among the more interesting events on the agenda...

by Kristi Marvin on 2024-02-24 at 11:45am

Terms Tracker for the Week Ending February 23, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As expected, new issuance filings were quiet this week.  But, deal announcements were surprisingly active.  Four more SPACs announced combinations in a shortened holiday week...

by Nicholas Alan Clayton on 2024-02-23 at 2:26pm

Pyrophyte (NYSE:PHYT) faced a major regulatory setback for its combination with mining firm Sio Silica this week, but a recent analogous SPAC deal could provide some encouragement for a path forward. Sio Silica is working to develop a high-grade silica mine in the Vivian Sands outside Winnipeg, Canada and it inked the $708 million combination...

by Nicholas Alan Clayton on 2024-02-23 at 1:37pm

News and Rumors JD Supra: Securities class action lawsuits against SPACs and de-SPACs increased only slightly in 2023 with 27 after 2022 saw 24 and 2021 – 33. Lawsuits concerning the de-SPACing process itself dropped precipitously, however, representing just 21% of cases as compared to 69% in the previous two years and 80% in 2020....


Copyright © 2023 SPACInsider, Inc. All Rights Reserved